Advisory Services Network’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.09M | Sell |
6,314
-1,779
| -22% | -$605K | 0.03% | 640 |
|
|
2025
Q4 | $3.22M | Buy |
8,093
+1,087
| +16% | +$481K | 0.05% | 438 |
|
|
2025
Q3 | $3.19M | Buy |
7,006
+591
| +9% | +$241K | 0.05% | 419 |
|
|
2025
Q2 | $2.52M | Sell |
6,415
-7,101
| -53% | -$1.96M | 0.04% | 473 |
|
|
2025
Q1 | $3.65M | Buy |
13,516
+7,248
| +116% | +$1.86M | 0.07% | 319 |
|
|
2024
Q4 | $1.47M | Sell |
6,268
-301
| -5% | -$79.2K | 0.03% | 594 |
|
|
2024
Q3 | $1.6M | Hold |
6,569
| – | – | 0.03% | 543 |
|
|
2024
Q2 | $1.6M | Buy |
+6,569
| New | +$1.04M | 0.03% | 543 |
|
|
2024
Q1 | – | Sell |
-299
| Closed | -$57.3K | – | 1518 |
|
|
2023
Q4 | $57.3K | Buy |
+299
| New | +$50.9K | ﹤0.01% | 1933 |
|
|
2023
Q2 | – | Sell |
-273
| Closed | -$54.7K | – | 1500 |
|
|
2023
Q1 | $54.7K | Sell |
273
-554
| -67% | -$116K | ﹤0.01% | 1973 |
|
|
2022
Q4 | $197K | Buy |
+827
| New | +$176K | 0.01% | 1277 |
|
|
2021
Q3 | – | Sell |
-50
| Closed | -$8K | – | 1449 |
|
|
2021
Q2 | $8K | Buy |
+50
| New | +$7.32K | ﹤0.01% | 2885 |
|
|
2021
Q1 | – | Sell |
-50
| Closed | -$6K | – | 1341 |
|
|
2020
Q4 | $6K | Sell |
50
-147
| -75% | -$19.6K | ﹤0.01% | 2624 |
|
|
2020
Q3 | $29K | Buy |
+197
| New | +$28K | ﹤0.01% | 1878 |
|
|
2020
Q2 | – | Sell |
-44
| Closed | -$5K | – | 1103 |
|
|
2020
Q1 | $5K | Buy |
+44
| New | +$5.08K | ﹤0.01% | 2452 |
|
|
2016
Q3 | – | Sell |
-10
| Closed | -$1K | – | 1985 |
|
|
2016
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 1727 |
|
|
2016
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 1561 |
|
|
2015
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 1405 |
|
|
2015
Q3 | $1K | Buy |
+10
| New | +$1.11K | ﹤0.01% | 1392 |
|
Other funds holding ALNY
VPM
VCM
